Your browser doesn't support javascript.
loading
Substance use on admission toxicology screen is associated with peri-injury factors and six-month outcome after traumatic brain injury: A TRACK-TBI Pilot study.
Yue, John K; Phelps, Ryan R L; Winkler, Ethan A; Deng, Hansen; Upadhyayula, Pavan S; Vassar, Mary J; Madhok, Debbie Y; Schnyer, David M; Puccio, Ava M; Lingsma, Hester F; Yuh, Esther L; Mukherjee, Pratik; Valadka, Alex B; Okonkwo, David O; Manley, Geoffrey T.
Afiliação
  • Yue JK; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA; Brain and Spinal Injury Center, Zuckerberg San Francisco General Hospital, San Francisco, CA, USA.
  • Phelps RRL; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA; Brain and Spinal Injury Center, Zuckerberg San Francisco General Hospital, San Francisco, CA, USA.
  • Winkler EA; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA; Brain and Spinal Injury Center, Zuckerberg San Francisco General Hospital, San Francisco, CA, USA.
  • Deng H; Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Upadhyayula PS; Department of Neurosurgery, University of California San Diego, San Diego, CA, USA.
  • Vassar MJ; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA; Brain and Spinal Injury Center, Zuckerberg San Francisco General Hospital, San Francisco, CA, USA.
  • Madhok DY; Department of Emergency Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Schnyer DM; Department of Psychology, University of Texas in Austin, Austin, TX, USA.
  • Puccio AM; Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Lingsma HF; Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Yuh EL; Brain and Spinal Injury Center, Zuckerberg San Francisco General Hospital, San Francisco, CA, USA; Department of Radiology, University of California San Francisco, San Francisco, CA, USA.
  • Mukherjee P; Brain and Spinal Injury Center, Zuckerberg San Francisco General Hospital, San Francisco, CA, USA; Department of Radiology, University of California San Francisco, San Francisco, CA, USA.
  • Valadka AB; Department of Neurosurgery, Virginia Commonwealth University, Richmond, VA, USA.
  • Okonkwo DO; Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Manley GT; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA; Brain and Spinal Injury Center, Zuckerberg San Francisco General Hospital, San Francisco, CA, USA. Electronic address: manleyg@neurosurg.ucsf.edu.
J Clin Neurosci ; 75: 149-156, 2020 May.
Article em En | MEDLINE | ID: mdl-32173156
ABSTRACT
Substance use is commonly associated with traumatic brain injury (TBI). We investigate associations between active substance use, peri-injury factors, and outcome after TBI across three U.S. Level I trauma centers. TBI subjects from the prospective Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) with Marshall computed tomography (CT) score 1-3, no neurosurgical procedure/operation, and admission urine toxicology screen (tox+/-) were extracted. Associations between tox+/-, comorbidities, hospital variables, and six-month functional (GOSE) and neuropsychiatric (PCL-C, BSI18, RPQ-13, SWLS) outcomes were analyzed. Multivariable regression was performed for associations significant on univariate analysis with odds ratios (mOR) presented. Significance assessed at p < 0.05. In 133 subjects, tox+/tox- were 29.1%/72.9%. Tox+ was younger (35.5/43.6-years, p = 0.018), trended toward male sex (80.6%/63.9%, p = 0.067), was associated with history of seizures (27.8%/10.3%, p = 0.012), self-reported substance use (44.4%/17.5%, p = 0.001), prior TBI (58.8%/34.1%, p = 0.009), GCS < 15 (69.4%/48.4%, p = 0.031) and blood alcohol level >0.08-mg/dl (55.6%/30.8%, p = 0.022). In CT-negative subjects, tox+ was associated with increased hospital admission (95.7%/66.7%, p = 0.034). At six-months, tox+ was associated with screening positive for post-traumatic stress disorder (PCL-C 40.0%/15.9%; mOR = 8.24, p = 0.022) and psychiatric symptoms (BSI18 40.0%/14.3%, mOR = 11.06, p = 0.023). Active substance use in TBI may confound GCS assessment, triage to higher level of care, and be associated with increased six-month neuropsychiatric symptoms. Substance use screening should be integrated into standard emergency/acute care TBI protocols to optimize management and resource utilization. Clinicians should be vigilant in providing education, counselling, and follow-up for TBI patients with substance use.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Toxicologia / Programas de Rastreamento / Transtornos Relacionados ao Uso de Substâncias / Lesões Encefálicas Traumáticas Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Toxicologia / Programas de Rastreamento / Transtornos Relacionados ao Uso de Substâncias / Lesões Encefálicas Traumáticas Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article